LISTEN: Despite Novel Virus, COVID Vaccine 'Based On Decades Of Research'

Connecticut Public Radio | By John Henry Smith

Published December 15, 2020 at 4:59 PM EST

With the Pfizer COVID-19 vaccine already here in Connecticut and the Moderna version reportedly close behind, the big question now is: Will enough of us actually take the vaccine? Recently, Yale infectious diseases specialist Dr. Manisha Juthani joined All Things Considered to talk about why we should not fear taking these new COVID vaccines.

Federal funding is gone.

Congress has eliminated all funding for public media.

That means $2.1 million per year that Connecticut Public relied on to deliver you news, information, and entertainment programs you enjoyed is gone.

The future of public media is in your hands.

All donations are appreciated, but we ask in this moment you consider starting a monthly gift as a Sustainer to help replace what’s been lost.

Donate

SOMOS CONNECTICUT is an initiative from Connecticut Public, the state’s local NPR and PBS station, to elevate Latino stories and expand programming that uplifts and informs our Latino communities. Visit CTPublic.org/latino for more stories and resources. For updates, sign up for the SOMOS CONNECTICUT newsletter at ctpublic.org/newsletters.

SOMOS CONNECTICUT es una iniciativa de Connecticut Public, la emisora local de NPR y PBS del estado, que busca elevar nuestras historias latinas y expandir programación que alza y informa nuestras comunidades latinas locales. Visita CTPublic.org/latino para más reportajes y recursos. Para noticias, suscríbase a nuestro boletín informativo en ctpublic.org/newsletters.

Federal funding is gone.

Donate